New report reveals extent of barriers to HIV prevention pill in England – while seven people still newly diagnosed with HIV every day

New report reveals extent of barriers to HIV prevention pill in England – while seven people still newly diagnosed with HIV every day

Publication date

Thursday, November 3, 2022
New research released today has revealed two thirds (65%) of people who want to access highly effective HIV prevention drug PrEP (pre-exposure prophylaxis) are unable to do so. This comes as the latest data from the UK Health Security Agency shows seven people are still being newly diagnosed with HIV every day in England.

Statement: We want access for all who need PrEP - Equitable access to PrEP Now

Statement: We want access for all who need PrEP - Equitable access to PrEP Now

Publication date

Wednesday, October 14, 2020

National AIDS Trust, Terrence Higgins Trust, PrEPster and 47 other HIV, health and equality organisations are today jointly calling for urgent action to ensure the benefits of the national roll out of PrEP – the HIV drug – means “no community is left behind”.

NAT statement supporting the Local Government Authorities' call for fully funded PrEP

NAT statement supporting the Local Government Authorities' call for fully funded PrEP

Publication date

Wednesday, February 12, 2020

Deborah Gold, Chief Executive at NAT (National AIDS Trust), said:

"The Government’s continued silence on both the future of PrEP and the overdue local government funding settlement is inexcusable. Without these announcements local authorities have neither the time nor the resources necessary to plan the HIV prevention and sexual health services that are needed from April. It is no longer a case of being down to the wire, we are now well past it.

NAT statement on universal availability to HIV prevention medication PrEP

NAT statement on universal availability to HIV prevention medication PrEP

Publication date

Friday, October 4, 2019

NAT statement on universal availability to HIV prevention medication PrEP

Kat Smithson, Director of Policy at (National AIDS Trust), said:

“NAT stands alongside the doctors who deliver the services to provide PrEP, in calling for it to be universally available to all who need it.”

HIV, PrEP, and the Right to Health

HIV, PrEP, and the Right to Health

This blog was originally published on HuffPost . It is seven years since PrEP (pre-exposure prophylaxis) – the drug taken by HIV-negative people that prevents HIV acquisition – was licensed for use in the USA. It is three years since NAT...

Brian Paddick talks about his PrEP use - NAT comment

Brian Paddick talks about his PrEP use - NAT comment

Publication date

Tuesday, July 3, 2018

Lord Paddick has today spoken of his use of the HIV prevention drug PrEP in a personal story shared on the Prepster website.

In the post he tells of his enduring anxiety around HIV, stemming from the early days of the epidemic when he says he may have avoided HIV acquisition because he was “playing it straight” and married at the time.

HIV prevention drug PrEP available on the NHS from September

HIV prevention drug PrEP available on the NHS from September

Publication date

Thursday, August 3, 2017

NHS England has announced that from September pre-exposure prophylaxis (PrEP) will be available through the NHS as part of a three-year trial. This announcement comes a year and a day after an historic win for NAT (National AIDS Trust) at the High Court that confirmed the NHS’s legal ability to fund the drug, which stops people from getting HIV.